Oncology Nurse Advisor

National, Trade/B2B

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

#1114257

United States

#357019

Health/Health Conditions and Concerns

#1017

Traffic sources

Monthly visitors

Articles

Young Adults with High-Grade Glioma Need Life-Stage-Specific Interventions

6 days ago | oncologynurseadvisor.com | Jennifer Larson

More tailored interventions are needed to address the unique challenges facing adolescents and young adults (AYAs) with high-grade glioma (HGG) and provide life-stage-appropriate support, according to a recent study published in Cancer Medicine. Although HGG is relatively rare in AYAs, this type of cancer poses specific challenges for these patients because it can hinder progression in education, career development, and relationships.
Tarlatamab Improves Overall Survival in Small Cell Lung Cancer

6 days ago | oncologynurseadvisor.com | Jaymin Kang

Topline data were announced from a phase 3 trial evaluating tarlatamab-dlle (Imdelltra®) for the treatment of small cell lung cancer (SCLC) in patients who progressed on or after a single line of platinum-based chemotherapy. Tarlatamab, a bispecific delta-like ligand 3-directed CD3 T-cell engager, received accelerated approval for the treatment of adult patients with extensive stage small cell lung cancer with disease progression on or after platinum-based chemotherapy in 2024.
FDA Approves Bevacizumab Biosimilar Jobevne

1 week ago | oncologynurseadvisor.com | Jaymin Kang

The Food and Drug Administration (FDA) has approved Jobevne™ (bevacizumab-nwgd), a biosimilar to Avastin® (bevacizumab). Jobevne is a vascular endothelial growth factor inhibitor indicated for the treatment of:Metastatic colorectal cancer:in combination with intravenous fluorouracil-based chemotherapy for first- or second-line treatment.
Secondary vs Primary Rectal Cancer Linked With Worse Survival

1 week ago | oncologynurseadvisor.com | natasha persaud

Secondary rectal cancer after prostate cancer radiation therapy appears to have distinct clinical genomic characteristics and worse survival odds than primary rectal cancer, investigators report. In a case-control study, investigators compared outcomes from 64 men with secondary rectal cancer and 604 male patients with primary rectal cancer treated from 1994 to 2022.
Prehabilitation Reduces Postoperative Complication Risk in Upper GI Cancer

1 week ago | oncologynurseadvisor.com | Jessica Nye

Postoperative complications were reduced in patients with upper gastrointestinal (GI) cancer who participated in a prehabilitation program consisting of exercise, nutritional guidance, and psychological support, according to results of a systematic review and meta-analysis published in PLoS One.
Cancer Patients Prefer Using Telemedicine for Informed Consent

2 weeks ago | oncologynurseadvisor.com | Jen Smith

Many cancer patients prefer using telemedicine over in-person visits when completing the informed consent process for a clinical trial, according to research published in JCO Oncology Practice. Researchers surveyed cancer patients who were first-time telemedicine users at Memorial Sloan Kettering Cancer Center from 2021 to 2023. There were 970 patients who discussed a clinical trial during their telemedicine visit.
Light-Intensity Physical Activity Improves QOL in Patients With Cancer Regardless of Pandemic Conditions

3 weeks ago | oncologynurseadvisor.com | Ryner Lai

Physical activity of a light intensity is a key predictor of the physical function aspect of quality of life (QOL) in patients with respiratory and digestive system cancers, both during and outside the COVID-19 pandemic, according to a study published in Supportive Care in Cancer. Cancer remains one of the leading causes of death globally. The progressive nature of cancer means that QOL is slowly compromised as patients deteriorate across physical and mental domains.
US Had Second Highest Number of Deaths From Mesothelioma in 2021

3 weeks ago | oncologynurseadvisor.com | Jen Smith

Data suggest that the United States had the second highest number of mesothelioma cases and the second highest number of deaths from mesothelioma in 2021. These data were published in Lung Cancer. For this study, researchers evaluated data from patients in 204 countries and territories who were diagnosed with mesothelioma between 1990 and 2021. The number of mesothelioma cases increased 93.5% over the study period, from 16,493 cases in 1990 to 31,908 cases in 2021.
Artificial Intelligence Model Developed to Better Predict the Early Recurrence of Hepatocellular Carcinoma

3 weeks ago | oncologynurseadvisor.com | Ryner Lai

Researchers developed an artificial intelligence model system that was effective at helping healthcare professionals identify patients with hepatocellular carcinoma (HCC) who were most at risk of early recurrence, potentially improving surveillance and treatment strategies, according to a study published in The Oncologist. HCC is one of the leading causes of cancer deaths globally. Early intervention is vital to improve prognosis and extend survival.
Telehealth Visits Reduced CT Simulation Cancellations for Patients With Breast Cancer

3 weeks ago | oncologynurseadvisor.com | Vicki Moore

The use of telehealth visits with an advanced practice provider was associated with significant improvements in patient preparedness and other positive outcomes for patients with breast cancer undergoing preparation for radiation therapy. These findings were presented at the 50th Annual ONS Congress by Sarah Ferrin, APRN-CNP, and Amber Nguyen, DNP, APRN-CNP, of the James Cancer Center at The Ohio State University Wexner Medical Center in Columbus, Ohio.